Agenix(澳大利亞)

Agenix

Agenix www.agenix.comAgenix創(chuàng)建于1982年，該公司是基于昆士蘭理工學(xué)院成立的一個(gè)生物制藥和研究集團(tuán)，該公司的主要業(yè)務(wù)是研發(fā)單克隆抗體診斷程序。該公司擁有兩個(gè)全資子公司，其中一個(gè)為AgenBiomedical，另一個(gè)為AgenixBiopharmaceutical，后者位于中國上海。AgenixlistedontheAustralianSecuritiesExchange in1987.Today,Agenix’sleadproductcandidateisThromboView®,anovelradio-labelledmonoclonalantibodyimagingmodalityforpulmonaryembolism(PE)anddeepveinthrombosis(DVT).ThromboView®hassuccessfullycompletedtwoU.S. FDAPhaseIIclinicaltrialsandisinpartneringdiscussionsforPhaseIIItrials.Agenix’shumanhealthdiagnosticsplatform,DiagnostIQ®isapatenteddisposablepoint-ofcaretestdevicewithreader.DiagnostIQ®utilisesanantibody/antigenprintedmembrane,auniquepre-filterdeviceandanincubationchamberinaflow-throughformattocreateasensitiveandquantitative,rapid,test.Thepatentedtechnologyprovidesthepotential